Gossamer Bio Announces Exchange Offer and Consent Solicitation for Convertible Senior Notes

Source Summary

DLA Piper has advised Cantor Fitzgerald & Co. Gossamer Bio, Inc., a biopharmaceutical company focused on developing treatments for pulmonary hypertension, has completed an exchange offer [...]